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Our aim was to investigate the activities of antioxidative defense 
enzymes in the placenta, fetal blood and amnion fluid in inherited 
thrombophilia. Thrombophilia was associated with nearly three-
fold increase of activity (p < 0.001) of the placental catalase (81.1 
± 20.6 U/mg of proteins in controls and 270.0 ± 69.9 U/mg in 
thrombophilic subjects), glutathione (GSH) peroxidase (C: 20.2 ± 
10.1 U/mg; T: 60.0 ± 15.5 U/mg), and GSH reductase (C: 28.9 
± 5.6 U/mg;  T: 72.7 ± 23.0 U/mg).  The placental activities of 
superoxide dismutating enzymes—MnSOD and CuZnSOD, did 
not differ in controls and thrombophilia. Likewise, the activities 
of catalase and SOD in the fetal blood, and the level of ascorbyl 
radical  which  represents  a  marker  of  oxidative  status  of  amni-
otic  fluid,  were  similar  in  controls  and  thrombophilic  subjects. 
From this we concluded that in thrombophilia, placental tissue 
is  exposed  to  H2O2-mediated  oxidative  stress,  which  could  be 
initiated by pro-thrombic conditions in maternal blood. Increased 
activity of placental H2O2-removing enzymes protects fetus and 
mother during pregnancy, but may increase the risk of postpartum 
thrombosis.
Introduction
Inherited  thrombophilia  represents  a  condition  that  predis-
poses individuals to thrombosis and thromboembolism, particularly 
during pregnancy.1,2 Under pro-thrombotic conditions related with 
both thrombophilia and pregnancy, haemostatic response and micro-
thrombi  are  generated,  which  could  lead  to  ischemic  conditions 
and mechanical stress in blood vessels and consequent generation 
of  reactive  oxygen  species  (ROS).3,4  Intricately  associated  with 
endothelium injury and coagulation is inflammation, under which 
increased activity of leukocytes results in oxidative burst.5 A cascade 
of events initiated by oxidative stress, leads to series of responses, 
such as vasoconstriction, membrane oxidation and further pro-coag-
ulation,3 each of which includes further generation of ROS.5-8 Such 
overproduction of ROS during pregnancy can damage placenta and 
affect the function of placental circulation.9 All the above implies a 
potential relation between pro-thrombotic conditions in pregnancy 
complicated by thrombophilia and oxidative stress which has not 
been previously clearly linked. Thus, the aim of this study was to 
assess the role of oxidative stress and to identify the most abundant 
reactive oxygen species in thrombophilia. We evaluated the activity 
of five major enzymes of antioxidative system (AOS): catalase, GSH 
peroxidase  and  reductase,  MnSOD  and  CuZnSOD  in  placental 
tissue  obtained  after  Caesarean  delivery  of  nine  individuals  with 
thrombophilia and of ten control subjects. The origin of oxidative 
stress was investigated by evaluating the oxidative status of the fetal 
blood and amniotic fluid.
Results
Figure  1  shows  activities  of  H2O2-scavenging  (catalase,  GSH 
peroxidase/reductase)  and  superoxide  dismutating  (MnSOD  and 
CuZnSOD) enzymes in placental tissue. It can be observed that the 
H2O2-scavenging enzymes were roughly three times more active in 
placentas of thrombophilic mothers than in controls. On the other 
hand, SOD activity was not modified in thrombophilia.
Native electrophoresis with staining specific for catalase or SOD 
activity was used to support results presented in Figure 1. Figure 2 
shows characteristic bands obtained from controls and thrombophilic 
placentas.  Quantification  of  the  enzymatic  activity  of  individual 
enzyme isoforms, performed by zymograms, showed that the activity 
of catalase in the control group was 33% of the activity of catalase 
determined in the thrombophilia group. The activity of CuZnSOD 
in the controls was 93% of its activity in thrombophilic individuals, 
while the MnSOD activity in thrombophilic subjects was 97% of the 
MnSOD activity in controls. This fully corresponds to the spectro-
photometric results.
Catalase and SOD activities in the fetal blood were evaluated 
in order to determine whether increased level of H2O2 in placental 
tissue originates from fetal circulation. Enzymes activity were similar 
in the blood obtained from the cord of newborns delivered after 
normal pregnancies and pregnancies associated with thrombophilia 
(Catalase: 16001 ± 3333 U/g of Hb in controls, 15311 ± 2284 U/g 
Hb in thrombophilia; Total SOD: 6952 ± 1101 U/g Hb in controls, 
6806 ± 499 U/g Hb in thrombophilia; p > 0.05).
Relative level of ascorbyl radical in amniotic fluid was evaluated 
using EPR spectroscopy, in order to determine oxidative status of 
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after delivery.22,23 We propose that at the delivery, after placenta is 
discarded, protection of maternal blood is instantaneously dimin-
ished.  While  the  generation  of  H2O2  should  continue,  exerting 
increased oxidative pressure on maternal blood. Such pro-oxidative 
conditions in maternal blood could promote development of throm-
bosis postpartum.
AOS, represented by functionally connected set of enzymes and 
low molecular mass components, have physiological role to to main-
tain cellular redox state and to neutralize and/or suppress oxidative 
damages induced by ROS. Abnormal activity of AOS or some of 
the fluid.10,11 Figure 3 shows characteristic spectra acquired from 
amniotic fluid of controls and pregnancies complicated by throm-
bophilia. Calculated amplitudes of EPR signal of ascorbyl radical did 
not differ (data not shown), demonstrating that the oxidative status 
of the amniotic fluid remains unchanged in thrombophilia.
Discussion
The  findings  demonstrate  that  oxidative  pressure  is  exerted 
on placenta in thrombophilia. Significant increase of activities of 
H2O2-removing enzymes (catalase and GSH peroxidase) shows that 
the major reactive specie affecting the placental tissue is hydrogen 
peroxide. It seems to be of extra-placental origin, since SOD activity 
as the principal source of H2O2 in tissues, remains unchanged in 
thrombophilia. Hydrogen peroxide can pass membranes of placental 
cells and therefore could be supplemented via fetal or maternal blood 
or by amniotic fluid. However, AOS activity in the fetal blood and 
oxidative status of amniotic fluid were not increased in thrombo-
philia. So, H2O2 is most likely distributed to placental tissue from 
mother’s blood and endothelium. There it can be generated in the 
chain-reaction  initiated  by  pro-thrombic  conditions  related  with 
thrombophilia.  Under  such  conditions  haemostatic  response  and 
micro-thrombi  can  lead  to  ischemia,  vessel  injury  and  to  related 
increased generation of ROS.3,4 Cascade of events can be activated, 
leading  to  vasoconstriction,  leukocyte  adhesion  and  infiltration, 
membrane  oxidation  and  further  pro-coagulation.3  Each  of  these 
particular  processes  includes  further  generation  of  ROS.5-8  We 
hypothesize that oxidative burst generated by such chain-reaction, 
could lead to increased level of H2O2 in thrombophilic placentas.
Hydrogen  peroxide  as  a  membrane-permeable  molecule  could 
initiate  a  variety  of  responses.  At  high  concentrations,  H2O2  can 
provoke  oxidative  damage  and  affect  various  signaling  pathways,12 
which could lead to dysfunction of placental cells.9 Placental blood 
flow, which is essential for the normal function of placenta and is crit-
ical for fetal development, could be also affected, since H2O2 is known 
to modulate vessel function in a complex way, acting as both a vaso-
constrictor and a vasodilator.13,14 As a vasoconstrictor, H2O2 could 
provoke reduced placental perfusion. The constancy of the placental 
perfusion may be even more important factor than the absolute rate of 
blood flow, as biphasic effect of H2O2 could lead to ischemia/reperfu-
sion oxidative injury.14 Depending on the severity and frequency of 
such assaults, the outcome might range from mild oxidative stress to 
severe damage of the placental tissue.15 On the other hand, increased 
level of H2O2 can not provoke uterine contractions in thrombophilic 
mothers,  since  H2O2  shows  only  relaxing  effects  on  myometrial 
smooth muscle (our unpublished observations on rat uteri), which is 
substantially different than any other smooth muscle.16
The  findings  confirm  the  previously  established  good  correla-
tion between the oxidative state of the mother and the neonate.17 
As  H2O2  can  provoke  such  vast  range  of  pathophysiological 
changes, placenta ought to defend itself in thrombophilia by AOS 
activation. If the protection fails, thrombophilia result into other 
pregnancy complications,18 and even miscarriage represents a poten-
tial outcome.19-21 Enzymes of AOS present in placenta may also 
partially protect maternal blood from excessive amounts of H2O2. 
If such protection fails during pregnancy, pro-thrombotic condition 
may lead to thrombosis. Until modern obstetrics made an impact, 
the risk of thrombosis was reaching peak postpartum, immediately 
Figure 1. Activity of AOS enzymes in the placental tissue. Results are pre-
sented as means ± S.D. Controls—white columns; Thrombophilia—black col-
umns. White star: statistically significant (p < 0.001); Black star: statistically 
insignificant (p > 0.05).
Figure 2. Isoenzyme pattern of the catalase enzyme on polyacrylamide gels 
after native electrophoresis and of the activity of SOD in polyacrylamide gels 
after isoelectrofocusing of placental tissue samples.Oxidative stress in thrombophilic pregnancies
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pregnancy complications,17 the application of methods that are able 
to determine oxidative status of tissues and fluids becomes more 
clinically relevant. Screening of the level of ascorbyl radical in amni-
otic fluid during pregnancy, or AOS activity in placental tissue or 
fetal blood postpartum could provide information that could indi-
cate development of some disorder, such as thrombophilia. Based 
on the obtained data, decision should be made whether to involve 
antioxidant therapy in order to prevent fetal injury or postpartum 
complications.
Patients and Methods
Patients.  Our study included nine pregnancies with inherited 
thrombophilia (study group) and ten normal pregnancies (control 
group). The demographic characteristics of the groups are presented 
in Table 1.
Inherited thrombophilias were detected by measuring the biolog-
ical activity of antithrombin and evaluating the presence of specific 
mutations—factor V Leiden and factor II 20210A.19 Among nine 
women in the study group: one had antithrombin deficiency, five 
resistance to activated protein C with factor V Leiden mutation and 
three factor II 20210A mutation. In all the patients the diagnosis of 
inherited thrombophilia was made only on the basis of pregnancy 
complications since none of them had history of thrombosis. Five 
patients were diagnosed before the index pregnancy, while the other 
four were diagnosed during the index pregnancy. All of them received 
therapeutic doses of low molecular weight heparin; those diagnosed 
before pregnancy from the beginning of the pregnancy and those 
diagnosed later immediately after the detection of thrombophilia. 
Anticoagulant therapy was continued during the postpartum period 
in all patients with thrombophilia. All patients (control and study 
group) received multivitamin supplement that contained 100 mg of 
vitamin C each day.
All of the nineteen patients were delivered by elective Cesarean 
section. In the study group Cesarean section had been done due to 
maternal complications, fetal distress or as iterative, while in the 
control group it had been as second iterative. All of the neonates were 
live-born. Intrauterine growth restriction, defined as estimated fetal 
and neonatal birth weight beyond 10th percentile for the gestational 
age, has been detected in five of nine cases with thrombophilia.
Institutional approval for the study was granted by The Clinics 
Ethics  Committee  in  accordance  with  internationally  accepted 
ethical standards (The Helsinki Declaration of 1964, as revised in 
1975, 1983 and 1989), and each patient had signed the informed 
consent form.
Samples.  Placentas  were  obtained  immediately  after  delivery. 
Placental  tissue  pieces  (six  per  placenta)  were  dissected  from 
different  cotyledons  midway  between  the  chorionic  and  basal 
plates.24 Six samples per each placenta were taken free of visible 
infarction,  calcification  or  hematoma.  The  tissue  samples  were 
immediately washed with ice-cold saline to remove blood. Cord 
blood  was  taken  immediately  after  the  delivery  in  commercial 
containers filled with citrate. Amniotic fluid of control patients was 
obtained at delivery. Specimens of placenta and amniotic fluid have 
been snap-frozen in liquid nitrogen and stored at -85°C. Citrate-
treated blood samples were centrifuged at 2,000 xg for 15 min at 
4°C, and the separated erythrocytes were washed three times with 
0.9% NaCl and than frozen.
its component(s) represent a straightforward proof of pro-oxidative 
conditions in any tissue. On the other hand, oxidative status of body 
fluids (e.g., extracellular fluid), which are poor in AOS enzymes, can 
be determined by the level of ascorbyl radical.11 Ascorbyl radical, 
which is generated via radical scavenging by ascorbate, is relatively 
stabile and readily detected using EPR spectroscopy.10,11 To the best 
of our knowledge, this is the first time that such approach was used 
on amniotic fluid.
As there are extensive evidences of the essential role of reactive 
species in the development of various disorders,12 among which are 
Table 1  Baseline characteristics
  Control  Thrombophilia  p value 
  (n = 10)  (n = 9)
Maternal age (years)  26.9 ± 3.9  29.3 ± 3.8  >0.05
Smokers (n (%))  2 (20)  1 (9)  >0.05
Gestational age (weeks)  38 ± 2  32 ± 3  >0.05
Neonate weight (g)  3457 ± 805  1388 ± 501  <0.05
Figure 3. Characteristic EPR spectra of the ascorbyl radical in amniotic fluid 
of  normal  and  thrombophilic  pregnancies.  Bottom  panel  shows  spectral 
simulation that was used as a reference for identification of this radical in 
amniotic fluid.Oxidative stress in thrombophilic pregnancies
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Statistical analysis. Measurements were performed on six separate 
placenta samples and one sample of amniotic fluid and fetal blood 
obtained from each patient. Statistical differences were evaluated by 
means of the non-parametric two-tailed Mann-Whitney test using 
Statistica 6.0 (StatSoft Inc., Tulsa, OK, USA). Results are presented 
as means ± S.D. (standard deviation) and were taken to be statisti-
cally different if p < 0.05.
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Spectrophotometric  assays.  Frozen  villous  tissues  were  thawed 
on ice and 1 g of wet fragments was homogenized in 10 volumes of 
ice-cold homogenizing buffer (50 mM Tris-HCl, 250 mM sucrose,   
1 mM EDTA, pH 7.4). The homogenates were centrifuged at 100,000 
xg at 4°C for 90 min. Protein contents in supernatants were deter-
mined using the method of Lowry. Supernatants were frozen in liquid 
nitrogen and stored at -85°C. Erythrocytes from fetal blood (0.5 ml) 
were lysed by adding 3 ml of ice-cold distilled water. Hemoglobin 
(Hb) concentration was measured by the Drabkin method.
SOD activity was measured according to the previously described 
method.25 Interference from hemoglobin was eliminated by precipi-
tation prior to the assay using ethanol/chloroform (1:1, v/v) that 
was followed by centrifugation at 3,000 xg for five minutes at 4°C. 
MnSOD activity was determined in the presence of 5 mM KCN that 
inhibits  the  activity  of  CuZnSOD.  Previously  described  methods 
were used to determine activities of catalase,26 GSH peroxidase27 and 
GSH reductase.28 The activity of the enzymes in the placental tissue 
was expresses as U/mg of proteins, while the activity of catalase and 
SOD in blood was presented as U/g of Hb.
Electrophoresis.  Native  polyacrylamide  gel  electrophoresis  was 
carried out under non-denaturing conditions in gels containing 8% 
polyacrylamide with a 4% stacking gel. A constant current of 25 mA 
per gel was applied. Electrophoresis buffers and gels were prepared 
as described previously,29 with the exception that SDS was excluded. 
Catalase was stained as previously described.30
In order to determine the SOD activity, non-equilibrated isoelec-
tric focusing was performed horizontally in the LKB 2117 Multiphor 
II system, using 0.5 mm thick polyacrylamide gels (5% T, 3% C) 
that contained 4% 3.5–10.0 ampholites. Gels were solidified with 
50 μL of 10 % ammonium persulfate and 7 μL of TEMED per 15 
mL of gel solution. Gels were run at 4°C with the constant power of 
0.25 W/cm width of gel, with limiting voltage of 1,000 V for two 
hours. SOD isoenzymes were detected on the gels by staining for 20 
minutes in the dark in 20 mL 100 mM sodium phosphate buffer pH 
7.8 with 4 mg of nitrobluetetrazolium, 0.6 mg of riboflavine, 2 μL of 
TEMED and 40 μL of 0.25 M NaEDTA. After that, the gels were 
briefly rinsed with distilled water and illuminated for 15 minutes. 
Quantification  of  enzyme  activity  of  individual  isoforms  was 
performed from zymograms, using the Image Master TotalLab v1.11 
(Amersham  Pharmacia  Biotech,  Piscataway;  NJ  USA)  program. 
Enzyme quantifications were all done in quadruplicate.
EPR study of oxidative status of amniotic fluid. Electron paramag-
netic resonance (EPR) measurements of the level of ascorbyl radical 
in amniotic fluid were performed in order to determine its oxidative 
status.10,11 Aliquots of the amniotic fluids were drawn into quartz 
capillaries. EPR spectra were recorded at room temperature using a 
Varian E104-A EPR spectrometer operating at X-band (9.51 GHz), 
with the following settings: modulation amplitude, 2 G; modulation 
frequency, 100 kHz; and microwave power of 10 mW. Spectra were 
recorded using EW software (Scientific Software; Bloomington, IL 
USA). Computer simulation of EPR spectrum of ascorbyl radical was 
performed using the WINEPR SimFonia computer program (Bruker 
Analytische Messtechnik GmbH; Rheinstetten, Germany) and spec-
tral parameter aH = 2.3. Simulation was used to identify signal and 
to calculate amplitudes.
All the chemicals used in this study were purchased from Sigma-
Aldrich (St. Louis, MO, USA) and Merck (Darmstadt, Germany).Oxidative stress in thrombophilic pregnancies
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